Results 171 to 180 of about 7,205 (185)

Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma

Cancer Chemotherapy and Pharmacology, 2007
Caroline Dive
exaly  

Clinical significance of serum M30 and M65 levels in patients with breast cancer

Biomedicine and Pharmacotherapy, 2014
Faruk Tas, Senem Karabulut, Ibrahim Yildiz   +2 more
exaly  

Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

Cancer Chemotherapy and Pharmacology, 2010
Ahmet Bilici, Şerif Ercan, Mahmut Gumus
exaly  

Serum profiles of M30, M65 and interleukin-17 compared with C-reactive protein in patients with mild and severe acute pancreatitis

Journal of Hepato-Biliary-Pancreatic Sciences, 2014
Fotini Papachristou
exaly  

Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls

Archives of Gynecology and Obstetrics, 2015
Savas Karakuş, Ali Çetin
exaly  

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain

Neuroscience, 2011
exaly  

Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody

Histopathology, 2001
exaly  

M30 CaC4H4O6·4H2O [(F)]

2006
openaire   +1 more source

Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomas

Histopathology, 2004
exaly  

Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis

Journal of Medical Virology, 2010
exaly